Physician profile
Daniel P Federowicz
NPI 1902820210
$2,691.92
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $1,228 · 2021: $429 · 2022: $185 · 2023: $251 · 2024: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $1,092.28 | 2020 | |
| Baxter Healthcare | $601.68 | 2019-2024 | Floseal, Tisseel |
| Endo Pharmaceuticals INC. | $232.60 | 2019-2023 | Xiaflex |
| Skeletal Dynamics INC | $229.47 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $173.25 | 2019-2021 | |
| Stryker Corporation | $108.94 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $98.16 | 2020 | |
| Heron Therapeutics, INC. | $89.42 | 2024 | Zynrelef |
| Ethicon US, LLC | $35.40 | 2019 | |
| Pacira Therapeutics, INC. | $22.42 | 2019 | |
| Orthofix Medical, INC. | $8.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Federowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.